SANDOMS INTERIORS LIMITED

Company number 07509654 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: C-

Explanation: Sandoms Interiors Limited is exhibiting acute symptoms of financial distress. While the business remains solvent (assets exceed liabilities), its financial immune system is severely compromised. A sudden drop in retained earnings indicates a significant loss in the latest financial year, and a drastic decline in cash reserves, coupled with ballooning short-term creditors, points to a severe liquidity crisis. The company is surviving on creditor finance rather than healthy cash generation.


1. Key Vital Signs

  • Pulse (Cash Position): Weak and rapid. Cash at bank has plummeted from a healthy £207,168 in 2024 to a dangerously low £31,075 in 2025. This 85% drop indicates the business is gasping for oxygen.
  • Blood Pressure (Liquidity Ratio): Dangerously high hypertension. Current liabilities have surged to £808,764 (up from £567,069), pressing hard against current assets of £876,850. The current ratio is 1.08, and the quick ratio (excluding stock) is 0.96. A quick ratio below 1 means that if all creditors demanded payment tomorrow, the company could not pay them without selling off stock.
  • Cholesterol (Debtors): Clogging the arteries. Debtors have swollen to £744,462 (up from £560,825). This suggests money is tied up with customers who are not paying fast enough, directly contributing to the cash flow anemia.
  • Weight Loss (Net Assets): Unhealthy deterioration. Net assets dropped by 42% from £312,843 in 2024 to £180,660 in 2025. The Profit and Loss reserve fell from £302,743 to £170,560, revealing an underlying loss of approximately £132,183 for the year.

2. Symptoms Analysis

The financial data reveals a classic "working capital squeeze." The business is doing the equivalent of running a marathon while holding its breath.

  • The Cash Flow Hemorrhage: The most alarming symptom is the near-evaporation of cash. While 2024 showed a robust cash position, 2025 tells a story of cash being consumed.
  • Reliance on Creditor Finance: To fund its operations and the surge in debtors, the company has leaned heavily on its suppliers. Short-term creditors have jumped by over £241,000. Using suppliers as a primary source of funding is like using adrenaline to keep running—it works temporarily, but it’s not sustainable and eventually leads to collapse if not addressed.
  • Inventory Build-up: Stocks have nearly doubled from £52,868 to £101,313. Combined with the high debtor levels, this suggests that goods are being pushed out to customers on credit, but the cash is not coming back in time to pay suppliers.

3. Diagnosis

Acute Liquidity Strain secondary to Profitability Shock.

The patient is not terminal (insolvent), but it is in the financial equivalent of the intensive care unit. The balance sheet still shows a positive net asset position, and long-term debt has been reduced (from £117,584 to £31,035), which shows some prudent financial management in the past. However, the 2025 fiscal year saw a severe heart attack in the P&L account, resulting in a substantial loss that has wiped out a large chunk of retained earnings.

The immediate threat to the business's survival is the mismatch in its working capital cycle: cash is tied up in unsold stock and unpaid invoices (debtors), while short-term bills (creditors) are piling up. If key suppliers demand payment or if major debtors default, the company could face a fatal cash seizure.


4. Prognosis

Guarded. The short-term outlook is highly dependent on the company's ability to collect outstanding debts. If the £744,462 owed by debtors is collectible and the stock is saleable, the business can stabilize. However, if customers continue to pay slowly, the company will struggle to meet its obligations, risking supplier withdrawals or formal recovery action. The reduction in long-term debt is a positive sign, but the immediate priority must be surviving the short-term cash crisis.


5. Recommendations

To restore financial wellness, the following urgent interventions are required:

  1. Cardioversion (Debt Collection): Immediately implement an aggressive credit control strategy. The £744k tied up in debtors is the company's lifeline. Chase outstanding invoices rigorously, consider offering early payment discounts, and tighten credit terms for new sales.
  2. Diet and Exercise (Inventory Management): Reduce the stock pile. The £101k in inventory needs to be converted to cash. Consider discounting slow-moving items to accelerate cash inflow rather than holding out for full margin on items that may never sell.
  3. Blood Pressure Medication (Creditor Negotiation): Proactively engage with major suppliers. Do not wait for them to chase. Negotiate extended payment terms or structured payment plans to ease the immediate pressure on the £808k in short-term liabilities.
  4. Transfusion (Funding Options): If internal collections are too slow, consider invoice financing (factoring) to unlock the cash tied up in the £744k debtor book. This acts as a financial blood transfusion, providing immediate working capital.
  5. Root Cause Analysis (Profitability Review): Conduct a deep dive into the 2025 trading performance. Understand exactly why the company went from a profitable position to a £132k loss. Was it margin erosion, unexpected costs, or a one-off write-off? Addressing the root cause is essential to prevent a relapse.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 7 August 2026